BDXのチャート
BDXの企業情報
| symbol | BDx |
|---|---|
| 会社名 | Becton Dickinson_Co （BDX ベクトン・ディッキンソン） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ベクトン・ディッキンソン（Becton Dickinson and Company）は医療用品、装置、実験装置および診断用製品を開発・製造・販売するグローバルな医療技術会社である。同社はBD医療事業とBD生命科学事業を運営する。BD医療事業は、各種のセッティングでヘルスケア提供を改善するために使用される一連の医療技術と医療機器を製造する。同事業は、糖尿病ケア、投薬および手続きソリューション、投薬管理ソリューション、医薬品システムなど、各ビジネスユニットで構成される。BD生命科学事業は感染症、医療関連感染症、およびがんを検出するために、診断標本、器具および試薬システムを安全に収集・輸送するための製品を提供する。同事業は、診断システム、バイオサイエンスなど、各ビジネスユニットが含まれる。 ベクトン・ディッキンソンは医療機器、検査室用器材、抗体、試薬、診断用製品を製造する。事業は3部門で構成。メディカル部門は注射針、静脈内カテ―テル、薬剤充填済みキット製品などを提供。ダイアグノスティクス部門は病院向けに採血管・キット、子宮頸がん診断用細胞検診製品など、またバイオサイエンス部門は乾細胞解析・分離装置などを製造する。 |
| 本社所在地 | 201 847-6800 |
| 代表者氏名 | Vincent A. Forlenza |
| 代表者役職名 | Chairman of the Board Chief Executive Officer |
| 電話番号 | +1 201-847-6800 |
| 設立年月日 | 1897年 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 50928人 |
| url | www.bd.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 4886.00000 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 67193.20000 |
| 売上高 | 売上高（百万ドル） 17062.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 87318.20000 |
| 当期純利益 | 当期純利益（百万ドル） 1316.00000 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 31 December 2018 Becton Dickinson and Co revenues increased 35% to $4.16B. Net income applicable to common stockholders excluding extraordinary items increased from $96M to $613M. Revenues reflect Interventional segment increase from $183M to $970M Medical segment increase of 15% to $2.14B United States segment increase of 44% to $2.39B International segment increase of 25% to $1.77B. |
BDXのテクニカル分析
BDXのニュース
Digital Genome Market 2021 Growth, Scope, COVID-19 Impact Analysis, Top Key Players And Forecast, 2027 | Agilent Technologies Inc., bioMerieux, Becton Dickinson and Company, Genomic Health Inc 2021/01/22 06:53:08 OpenPR
Allied Market Research published a new report, titled, "Digital Genome Market Global Opportunity Analysis and Industry Forecast, 2020-2027". The report has offered an all-inclusive analysis of the global Digital Genome Market taking into consideration all the crucial aspects like growth factors,
DNA Probes based Diagnostics Market SWOT Study and Revenue Key Manufacturers | Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson & Company, BioMerieux 2021/01/21 23:21:36 OpenPR
The new report on the DNA Probes-based Diagnostics market provides estimations of the size of the global market and share and size of key regional markets during the historical period of 2015 – 2019. As a result, DNA probes-based technology
Biotherapeutics Cell Line Development Market with Pandemic Analysis, Growth Rate, New Trend Analysis Forecast To 2027 | Becton Dickinson and Company, Beckman Coulter, Boehringer Ingelheim Group, Catalent 2021/01/20 17:12:18 OpenPR
Biotherapeutic drug products encompass various active substances. These substances are either produced or extracted from biological sources. These biotherapeutic drug therapy products are obtained from various recombinant DNA technologies such as interleukins, interferons, etc. There are various advantages of these
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic (Becton Dickinson) | CompanyNewsHQ 2021/01/20 11:18:11 CompanyNewsHQ
(Becton Dickinson) For Immediate ReleaseChicago, IL – January 20, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity
Knee Implants Market 2026: Industry Analysis, Outlook and Forecast Research Report: Top Key Players are B. Braun, Smith & Nephew, Zimmer Biomet Holding Inc., Stryker, Exactech, Johnson & Johnson, DJO Surgical, Medtronic, Becton Dickinson 2021/01/16 19:50:04 OpenPR
ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Knee Implants Market Research Report 2020”. The Global Knee Implants Market Report is a professional and in-depth study on the current state of the Knee Implants Market. The
RNA Sample Preparation Market Share and SWOT Analysis: Thermo Fisher Scientific Inc, Becton, Dickinson & Company, DiaSorin S.p.A 2020/11/25 12:40:37 OpenPR
The Global RNA Sample Preparation Market 2020 Market Research Report is a professional and in-depth study on the current state of the RNA Sample Preparation industry. Industry Overview: Updated research report on RNA Sample Preparation Market by ‘Market Growth Insight’ delivers pivotal
Lateral Flow Assays Market worth USD 10.2 billion by 2025 - Leading Companies are Abbott Laboratories, F. Hoffman-La Roche Ltd, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, and bioMérieux SA 2020/11/25 11:20:38 OpenPR
According to the new market research report "Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025", published
Surgical Instrument Tracking Systems Market - Detailed Analysis of Current and Future Industry Figures till 2027 | Censis, Becton Dickinson, MMMicrosystems, Getinge 2020/11/20 11:06:00 OpenPR
Surgical Instruments Tracking System is the system that consolidates with examining innovation and application programming. Surgical instrument is a remarkably organized gadget or contraption for performing unequivocal exercises or finishing needed effects during a restorative method or action, for instance,
Flow Cytometry Market Rapidly Develop | Becton Dickinson and Company, General Electric Company, Luminex Corporation 2020/11/18 09:02:58 OpenPR
Flow cytometry is a laser-based or impedance-based biophysical technology employed in cell counting, cell sorting, biomarker detection, and protein engineering. The process is conducted by suspending cells in a stream of fluid and passing them through an electronic detection apparatus.
Elon Musk questions coronavirus tests, after getting two positive and two negative results 2020/11/13 07:35:41 South China Morning Post
Tesla CEO Elon Musk said on Thursday he took four coronavirus tests on the same day, with two showing positive results, while the other two were negative.“Something extremely bogus is going on. Was tested for covid four times today. Two tests came back negative, two came back positive. Same machine, same test, same nurse. Rapid antigen test from BD,” Musk said in a tweet, possibly referring to Becton Dickinson and Co’s rapid antigen test.The Tesla CEO said he was also undergoing polymerase…